FPR2 resolves inflammation by promoting non-phlogistic apoptosis, leukocyte phagocytosis, cell adhesion molecule shedding, and releasing anti-inflammatory cytokines in the tissues, thus being involved in ameliorating inflammatory storms in the early stages of reperfusion following stroke (Smith et al., 2015). The gene discussed is FPR2; the disease is Stroke.